These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1998534)

  • 1. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro.
    O'Brian CA; Fan D; Ward NE; Dong Z; Iwamoto L; Gupta KP; Earnest LE; Fidler IJ
    Biochem Pharmacol; 1991 Mar; 41(5):797-806. PubMed ID: 1998534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of phorbol ester-induced downregulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells.
    Ward NE; O'Brian CA
    Cancer Lett; 1991 Jul; 58(3):189-93. PubMed ID: 1855195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells.
    O'Brian CA; Fan D; Ward NE; Seid C; Fidler IJ
    FEBS Lett; 1989 Mar; 246(1-2):78-82. PubMed ID: 2707442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; Earnest LE; van Boom JH; Fan D
    Invest New Drugs; 1991 May; 9(2):169-79. PubMed ID: 1874600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming murine tumor cell resistance to vinblastine by presentation of the drug in multilamellar liposomes consisting of phosphatidylcholine and phosphatidylserine.
    Seid CA; Fidler IJ; Clyne RK; Earnest LE; Fan D
    Sel Cancer Ther; 1991; 7(3):103-12. PubMed ID: 1771296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
    Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
    Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
    Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC
    Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.
    Blobe GC; Sachs CW; Khan WA; Fabbro D; Stabel S; Wetsel WC; Obeid LM; Fine RL; Hannun YA
    J Biol Chem; 1993 Jan; 268(1):658-64. PubMed ID: 8093247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant phenotype on rat fibroblasts.
    Fan D; Fidler IJ; Ward NE; Seid C; Earnest LE; Housey GM; O'Brian CA
    Anticancer Res; 1992; 12(3):661-7. PubMed ID: 1622123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes.
    Fan D; Bucana CD; O'Brian CA; Zwelling LA; Seid C; Fidler IJ
    Cancer Res; 1990 Jun; 50(12):3619-26. PubMed ID: 2340511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
    Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
    Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic behavior of an adriamycin-resistant murine tumor.
    Giavazzi R; Miller L; Hart IR
    Cancer Res; 1983 Nov; 43(11):5081-6. PubMed ID: 6616446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of murine fibrosarcoma cells to drugs affected by the multidrug resistance phenotype by the antidepressant trazodone - an experimental-model for the reversal of intrinsic drug-resistance.
    Fan D; Poste G; Obrian C; Seid C; Ward N; Earnest L; Fidler I
    Int J Oncol; 1992 Dec; 1(7):735-42. PubMed ID: 21584609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants.
    Bucana CD; Giavazzi R; Nayar R; O'Brian CA; Seid C; Earnest LE; Fan D
    Exp Cell Res; 1990 Sep; 190(1):69-75. PubMed ID: 2387329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
    Schwartz GK; Arkin H; Holland JF; Ohnuma T
    Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells.
    Gravitt KR; Ward NE; Fan D; Skibber JM; Levin B; O'Brian CA
    Biochem Pharmacol; 1994 Jul; 48(2):375-81. PubMed ID: 8053934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.
    Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA
    Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of tumor growth inhibitory activity of macrophages exposed to adriamycin and adriamycin sensitivity of the target tumor cells.
    Giavazzi R; Bucana CD; Hart IR
    J Natl Cancer Inst; 1984 Aug; 73(2):447-55. PubMed ID: 6589436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.
    Staroselsky AN; Fan D; O'Brian CA; Bucana CD; Gupta KP; Fidler IJ
    Cancer Res; 1990 Dec; 50(24):7775-80. PubMed ID: 2253220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.